Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Latino Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) in Treatment-Naive Patients With Chronic Hepatitis C-Genotype 1.

ClinicalTrials.gov ID: NCT00107653

Public ClinicalTrials.gov record NCT00107653. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 9:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Multicenter, Open-label, Comparative, Efficacy Study of Pegasys® Plus Copegus® in Treatment-naïve Latino Patients With Chronic Hepatitis C-genotype 1, as Compared to Treatment-naïve Non- Latino Caucasian Patients With Chronic Hepatitis C-genotype 1

Study identification

NCT ID
NCT00107653
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
569 participants

Conditions and interventions

Interventions

  • Peginterferon alfa-2a Drug
  • Ribavirin Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2004
Primary completion
Aug 31, 2007
Completion
Aug 31, 2007
Last update posted
Jun 20, 2016

2004 – 2007

United States locations

U.S. sites
58
U.S. states
20
U.S. cities
49
Facility City State ZIP Site status
Not listed Scottsdale Arizona 85259
Not listed Tucson Arizona 85712
Not listed Anaheim California 92801
Not listed Fountain Valley California 92708
Not listed Fresno California 93721
Not listed Lancaster California 93534
Not listed Los Angeles California 90022
Not listed Los Angeles California 90033
Not listed Los Angeles California 90095
Not listed Palo Alto California 94304-1509
Not listed Redlands California 92373
Not listed Sacramento California 95817
Not listed San Bernardino California 92404
Not listed San Diego California 92103-8465
Not listed San Diego California 92123
Not listed San Diego California 92154
Not listed San Diego California 92161
Not listed San Francisco California 94110
Not listed San Luis Obispo California 93401
Not listed Ventura California 93003
Not listed Pueblo Colorado 81008
Not listed Boca Raton Florida 33428
Not listed Bradenton Florida 34209
Not listed Miami Florida 33125
Not listed North Miami Beach Florida 33162
Not listed Plantation Florida 33324
Not listed Austell Georgia 30106
Not listed Chicago Illinois 60612
Not listed Chicago Illinois 60637
Not listed Gurnee Illinois 60031
Not listed Indianapolis Indiana 46202
Not listed Baton Rouge Louisiana 70890
Not listed New Orleans Louisiana 70115
Not listed Baltimore Maryland 21205
Not listed Framingham Massachusetts 01702
Not listed Worcester Massachusetts 01655
Not listed St Louis Missouri 63110
Not listed Vineland New Jersey 08360
Not listed Bayside New York 11358
Not listed New York New York 10029
Not listed Rochester New York 14618
Not listed Chapel Hill North Carolina 27599-7584
Not listed Fayetteville North Carolina 28304
Not listed Philadelphia Pennsylvania 19107
Not listed Philadelphia Pennsylvania 19141
Not listed Nashville Tennessee 37211
Not listed Dallas Texas 75203
Not listed Fort Sam Houston Texas 78234-3879
Not listed Fort Worth Texas 76107
Not listed Galveston Texas 77555
Not listed Houston Texas 77030
Not listed Houston Texas 77090
Not listed San Antonio Texas 78215
Not listed San Antonio Texas 78258
Not listed Salt Lake City Utah 84121
Not listed Fairfax Virginia 22031
Not listed Seattle Washington 98133
Not listed Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00107653, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 20, 2016 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00107653 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →